Bitauto Hldg Ltd (ADR) (BITA), Aurinia Pharmaceuticals Inc (AUPH): Tiger Global and RA Capital Disclose Their Latest Moves

Nevertheless, taking into account that over the last three years, Bitauto Hldg Ltd (ADR) (NYSE:BITA)’s stock has performed very well, surging by more than eightfold, the stock of the Internet content and advertising company, which operates in the automobile segment, is worth keeping for the long-run. The same idea is shared by 16 other funds aside from Tiger Global, although their stakes are much much smaller. For example, the second-largest position in Bitauto Hldg Ltd (ADR) (NYSE:BITA) among the funds that we track, is held by another Tiger Cub, Jesse Ro’s Tiger Legatus Capital, which initiated a stake that contains 148,400 shares during the fourth quarter.

Let’s move on to Aurinia Pharmaceuticals Inc (NASDAQ:AUPH), in which RA Capital has increased its stake. Aurinia is a micro-cap biotechnology company, whose stock is up by 23% since the beginning of the year. Mr. Kolchinsky added the stock to his fund’s equity portfolio during the last three months of 2014 and the latest increase comes after Aurinia announced its participation in the Cowen and Company 35th Annual Health Care Conference at the beginning of March.

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) is currently conducting a Phase 2b clinical trial of its drug, voclosporin, used for the treatment of lupus nephritis, which is an inflammation of the kidneys that can lead to renal disease. Another fund betting on Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) is Baker Bros. Advisors, led by Julian and Felix Baker, which holds around 727,700 shares as of the end of 2014. Baker Bros scored big earlier this month when its massive investment in promising biotech firm Pharmacyclics Inc (NASDAQ:PCYC) eclipsed $1.2 billion in returns for the year, following that company’s sale to AbbVie Inc (NYSE:ABBV). 

Disclosure: None